New York ends mask requirement for subways, buses and other mass transit

New York ends mask requirement for subways, buses and other mass transit


A Metropolitan Transportation Authority (MTA) logo is displayed on the side of a subway train in Manhattan, New York on June 2, 2021.

Ed Jones | AFP | Getty Images

New Yorkers are no longer required to wear masks on mass transit, Gov. Kathy Hochul announced on Wednesday.

Hochul said the decision to lift the mandate is based on declining infections, hospitalizations and the availability of new boosters that the target the dominant omicron subvariant BA.5.

“We do believe that we’re in a good place right now, especially if New Yorkers take advantage of this booster. That is how we get back to not just a new normal, but a normal normal, and that is what we’re striving for,” Hochul said during a news conference.

New York instituted mask mandates on public transit more than two years ago when the city was the epicenter of Covid in the U.S. Many New Yorkers started ignoring the mandate in the spring after near universal compliance early in the pandemic.

Masks are still required in nursing homes and hospitals, Hochul said.

New York State Health Commissioner Dr. Mary Bassett said the omicron boosters are expected to provide better protection against infection since the shots now match the dominant variant, though there’s no data on the effectiveness of the shots yet.

Covd hospitalizations in New York have declined more than 80% since the peak of the omicron surge in January.

This is breaking news. Please check back for updates.

CNBC Health & Science

Read CNBC’s latest global health coverage:



Source

Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale
Health

Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale

Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill market. Eli Lilly stock slipped about half a percent this morning, while Novo Nordisk shares surged more than 8% after becoming the first to secure FDA approval for a GLP-1 weight-loss pill. “[Novo] got approval ahead of […]

Read More
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
Health

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, Nov. 24, 2025. Tom Little | Reuters The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts […]

Read More
UnitedHealth Group commits to improvements after independent audit, patient backlash
Health

UnitedHealth Group commits to improvements after independent audit, patient backlash

UnitedHealthcare sign is displayed at its office building in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans | Reuters UnitedHealth Group on Friday released the first results from a sprawling independent audit of its business practices and committed to a wide range of steps to track and implement improvements in three specific areas. The health-care […]

Read More